AR069548A1 - Sales de propionato de 3-(2,2,2- trimetilhidrazinio ) en el tratamiento de la enfermedad cardiaca isquemica y uso medico - Google Patents
Sales de propionato de 3-(2,2,2- trimetilhidrazinio ) en el tratamiento de la enfermedad cardiaca isquemica y uso medicoInfo
- Publication number
- AR069548A1 AR069548A1 ARP080105238A ARP080105238A AR069548A1 AR 069548 A1 AR069548 A1 AR 069548A1 AR P080105238 A ARP080105238 A AR P080105238A AR P080105238 A ARP080105238 A AR P080105238A AR 069548 A1 AR069548 A1 AR 069548A1
- Authority
- AR
- Argentina
- Prior art keywords
- heart disease
- treatment
- ischemical
- hydrazin
- trimethyl
- Prior art date
Links
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title abstract 2
- 208000019622 heart disease Diseases 0.000 title 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-M fumarate(1-) Chemical compound OC(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-M 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicacion 1: Uso de la sal propionato de 3-(2,2,2-trimetilhidrazinio) seleccionada del grupo que consiste en fosfato de dihidrogeno y fumarato de hidrogeno para la manufactura de un medicamento para el tratamiento de la enfermedad cardiaca isquémica. Reivindicacion 3: Uso de acuerdo con la reivindicacion 1, o la reivindicacion 2, donde la enfermedad cardíaca isquémica es infarto del miocardio.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122359 | 2007-12-05 | ||
| EP07122360 | 2007-12-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR069548A1 true AR069548A1 (es) | 2010-02-03 |
Family
ID=40364183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080105238A AR069548A1 (es) | 2007-12-05 | 2008-12-02 | Sales de propionato de 3-(2,2,2- trimetilhidrazinio ) en el tratamiento de la enfermedad cardiaca isquemica y uso medico |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US20110028438A1 (es) |
| EP (1) | EP2222376B1 (es) |
| JP (1) | JP2011506285A (es) |
| KR (1) | KR20100084687A (es) |
| CN (1) | CN101951991A (es) |
| AR (1) | AR069548A1 (es) |
| AT (1) | ATE503473T1 (es) |
| AU (1) | AU2008333263A1 (es) |
| BR (1) | BRPI0819055A2 (es) |
| CA (1) | CA2706357C (es) |
| CL (1) | CL2008003552A1 (es) |
| CO (1) | CO6280507A2 (es) |
| DE (1) | DE602008005930D1 (es) |
| DK (1) | DK2222376T3 (es) |
| DO (1) | DOP2010000162A (es) |
| EA (1) | EA016971B1 (es) |
| GE (1) | GEP20125646B (es) |
| HR (1) | HRP20110468T1 (es) |
| IL (1) | IL205962A0 (es) |
| MA (1) | MA31992B1 (es) |
| MX (1) | MX2010006257A (es) |
| MY (1) | MY158799A (es) |
| NZ (1) | NZ586518A (es) |
| PA (1) | PA8806001A1 (es) |
| PE (1) | PE20091209A1 (es) |
| PL (1) | PL2222376T3 (es) |
| PT (1) | PT2222376E (es) |
| RS (1) | RS51785B (es) |
| SI (1) | SI2222376T1 (es) |
| SV (1) | SV2010003585A (es) |
| TN (1) | TN2010000249A1 (es) |
| TW (1) | TWI391131B (es) |
| UA (1) | UA100249C2 (es) |
| UY (1) | UY31499A1 (es) |
| WO (1) | WO2009071586A2 (es) |
| ZA (1) | ZA201003640B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS55092B1 (sr) * | 2011-04-27 | 2016-12-30 | Grindeks Jsc | Upotreba 3-karboksi-n-etil-n,n-dimetilpropan-1-aminijum soli u lečenju kardiovaskularne bolesti |
| RU2457198C1 (ru) * | 2011-05-31 | 2012-07-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью |
| RU2467748C1 (ru) * | 2011-08-08 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE386014T1 (de) * | 2003-08-04 | 2008-03-15 | Grindeks Jsc | Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung |
| LV13280B (en) * | 2003-08-04 | 2005-11-20 | Grindeks Publiska As | Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof |
-
2008
- 2008-11-26 TW TW097145679A patent/TWI391131B/zh not_active IP Right Cessation
- 2008-11-27 PE PE2008001983A patent/PE20091209A1/es not_active Application Discontinuation
- 2008-11-28 CL CL2008003552A patent/CL2008003552A1/es unknown
- 2008-11-28 PA PA20088806001A patent/PA8806001A1/es unknown
- 2008-11-28 UY UY31499A patent/UY31499A1/es not_active Application Discontinuation
- 2008-12-02 AR ARP080105238A patent/AR069548A1/es unknown
- 2008-12-03 DE DE602008005930T patent/DE602008005930D1/de active Active
- 2008-12-03 UA UAA201006836A patent/UA100249C2/uk unknown
- 2008-12-03 CN CN200880119405XA patent/CN101951991A/zh active Pending
- 2008-12-03 EA EA201000739A patent/EA016971B1/ru unknown
- 2008-12-03 MY MYPI2010002604A patent/MY158799A/en unknown
- 2008-12-03 NZ NZ586518A patent/NZ586518A/en not_active IP Right Cessation
- 2008-12-03 BR BRPI0819055 patent/BRPI0819055A2/pt not_active IP Right Cessation
- 2008-12-03 US US12/734,785 patent/US20110028438A1/en not_active Abandoned
- 2008-12-03 RS RS20110276A patent/RS51785B/en unknown
- 2008-12-03 SI SI200830294T patent/SI2222376T1/sl unknown
- 2008-12-03 WO PCT/EP2008/066712 patent/WO2009071586A2/en active Application Filing
- 2008-12-03 GE GEAP200811833A patent/GEP20125646B/en unknown
- 2008-12-03 PL PL08857821T patent/PL2222376T3/pl unknown
- 2008-12-03 DK DK08857821.6T patent/DK2222376T3/da active
- 2008-12-03 MX MX2010006257A patent/MX2010006257A/es active IP Right Grant
- 2008-12-03 JP JP2010536439A patent/JP2011506285A/ja not_active Ceased
- 2008-12-03 AU AU2008333263A patent/AU2008333263A1/en not_active Abandoned
- 2008-12-03 PT PT08857821T patent/PT2222376E/pt unknown
- 2008-12-03 AT AT08857821T patent/ATE503473T1/de active
- 2008-12-03 KR KR1020107012217A patent/KR20100084687A/ko not_active Application Discontinuation
- 2008-12-03 CA CA2706357A patent/CA2706357C/en not_active Expired - Fee Related
- 2008-12-03 EP EP08857821A patent/EP2222376B1/en active Active
-
2010
- 2010-05-21 ZA ZA2010/03640A patent/ZA201003640B/en unknown
- 2010-05-25 IL IL205962A patent/IL205962A0/en unknown
- 2010-06-01 TN TN2010000249A patent/TN2010000249A1/fr unknown
- 2010-06-02 DO DO2010000162A patent/DOP2010000162A/es unknown
- 2010-06-03 CO CO10067247A patent/CO6280507A2/es not_active Application Discontinuation
- 2010-06-04 SV SV2010003585A patent/SV2010003585A/es not_active Application Discontinuation
- 2010-07-01 MA MA32977A patent/MA31992B1/fr unknown
-
2011
- 2011-06-21 HR HR20110468T patent/HRP20110468T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2545959T3 (es) | Un medicamento consistente en un derivado de carboestirilo y donepezilo para el tratamiento de la enfermedad de Alzheimer | |
| CO2018006358A2 (es) | Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert | |
| AR067024A1 (es) | Metabolitos del inhibidor de janus quinasa (r)-3-(4-(7h-pirrolo(2,3-d)pirimidin-4-il)-1h-pirazol-1-il)-3-ciclopentilpropanonitrilo | |
| NO20071243L (no) | Substituterte biarylpiperazinylpyridinanaloger. | |
| CR11510A (es) | Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer | |
| CO2020013600A2 (es) | Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak | |
| CL2011000798A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| PA8748101A1 (es) | Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus | |
| CL2011000806A1 (es) | Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular. | |
| ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| BRPI0919020A2 (pt) | Uso de células de linhagem monocitária enriquecidas para tratar isquemia e para tratar angina pectoris | |
| AR112284A1 (es) | Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico | |
| UY30158A1 (es) | Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
| AR104068A1 (es) | Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer | |
| BR112014012054A2 (pt) | métodos de tratamento com deferiprona | |
| ATE543492T1 (de) | Behandlung von lungenkrebs | |
| AR069548A1 (es) | Sales de propionato de 3-(2,2,2- trimetilhidrazinio ) en el tratamiento de la enfermedad cardiaca isquemica y uso medico | |
| AR081925A1 (es) | Uso de ranolazina para el tratamiento de la hipertension pulmonar | |
| FR2936149B1 (fr) | Utilisation de l'alverine dans le traitement des affections cutanees | |
| ECSP077843A (es) | Tratamiento o prevención del prurito | |
| AR069521A1 (es) | Sales de propionato de 3 (2,2,2- trimetilhidrazinio) para la profilaxis y el tratamiento de la ateroesclerosis y uso medico | |
| PE20030277A1 (es) | Composicion farmaceutica que comprende 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y l-dopa | |
| EA200970021A1 (ru) | Комбинированные препараты, содержащие slv308 и l-dopa | |
| BR112021024099A2 (pt) | Composição farmacêutica para diabetes mellitus | |
| ECSP003441A (es) | Inhibidores de renina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |